Top compounds associated with response to FAM160B2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.01
mRNA Zebularine CTRPv2 pan-cancer AAC 0.086 0.01
mRNA Axitinib FIMM pan-cancer AAC 0.37 0.01
mRNA T0901317 GDSC1000 pan-cancer AAC -0.082 0.01
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.081 0.01
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.01
mRNA 5-FU CTRPv2 pan-cancer AAC 0.083 0.01
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.08 0.01
mRNA masitinib GDSC1000 pan-cancer AAC 0.078 0.01
Download CSV